What Causes Motoneuron Disease?
Editorial, Lancet 336:1033-10351990., , 1990
Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
Sustained Enteral Administration of Levodopa Increases and Interrupted Infusion Decreases Levodopa Dose Requirements
Neurol 40:995-997, Cedarbaum,J.M.,et al, 1990
Apomorphine Test to Predict Dopaminergic Responsiveness in Parkinsonian Syndromes
Lancet 336:32-34, Hughes,A.J.,et al, 1990
Two Decades of Increasing Mortality from Parkinson's Disease Among the US Elderly
Arch Neurol 47:731-734, Lilienfeld,D.E.,et al, 1990
Pyramid Sale in the Bucket Shop:DATATOP Bottoms Out
Neurol 40:1337-1339, Landau,W.M., 1990
Parkinsonism Due to a Basal Ganglia Lacunar State:Clinicopathologic Correlation
Neurol 40:897-900, Murrow,R.W.,et al, 1990
Cell Implantation in Parkinson's Disease
BMJ 301:301-302, Williams,A., 1990
Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease
Arch Neurol 47:505-512, Freed,C.R.,et al, 1990
Parkinson's Disease, Review Article
Lancet 335:948-952, Marsden,C.D., 1990
Magnetic Resonance Imaging in Parkinson's Disease
Arch Neurol 47:735-737, Huber,S.J.,et al, 1990
Clozapine in the Treatment of Parkinsonian Patients with Dopaminomimetic Psychosis
Neurol 40:832-834, Wolters,E.Ch.,et al, 1990
Decreased Efficacy of Levodopa with Carbidopa in Parkinsonian Patients after Adrenal-to-Caudate Implants
Neurol 40:845-846, Tsui,J.K.C.,et al, 1990
Parkinson's Disease and Driving Ability
JNNP 53:580-582, Madeley,P.,et al, 1990
HTLV-I Sequences Are Not Detected in Peripheral Blood Genomic DNA or in Brain cDNA of MS Patients
Ann Neurol 28:574-577, Oksenberg,J.R.,et al, 1990
Failure to Detect Human T-Cell Leukemia Virus-Related Sequences in Multiple Sclerosis Blood
Arch Neurol 47:1064-1065, Chen,I.S.Y.,et al, 1990
No Evidence for Human T-Cell Leukemia Virus Type I or Human T-Cell Leukemia Virus Type II Infection in Patients with MS
Arch Neurol 47:1061-1063, Perl,A.,et al, 1990
Risk Factors for Multiple Sclerosis:Race or Place? Editorial
JNNP 53:821-823, 903, 906990., Compston,A., 1990
Movement Disorders in Alcoholism:A Review
Neurol 40:741-746, Neiman,J.,et al, 1990
A Brain Transplant that Works
Lancet 335:445-446, , 1990
Medical Applications of Fetal Tissue Transplantation
Council Report, JAMA 263:565-5701990., , 1990
Adrenal Medullary Transplant to the Striatum of Patients with Advanced Parkinson's Disease
Neurol 40:273-276, Goetz,C.G.,et al, 1990
The Modern Management of Parkinson's Disease, Editorial
JNNP 53:93-95, Quinn,N., 1990
Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990
Extrapyramidal Involvement in Rett's Syndrome
Neurol 40:293-295, FitzGerald,P.M.,et al, 1990
A Comparison of Effects of Controlled-Release Levodopa (Madopar CR) with Levodopa in Late Parkinson's Disease
JNNP 53:220-223, MacMahon,D.G.,et al, 1990
The Fallacy of the Lacune Hypothesis
Stroke 21:1251-1257, Millikan,C.&Futrell,N., 1990
PET Study in Progressive Supranuclear Palsy, Hypometabolic Pattern
Arch Neurol 47:747-752, Blin,J.,et al, 1990
Retroviruses and Multiple Sclerosis. I. Analysis of Seroreactivity by Western Blot and Radioimmune Assay
Neurol 40:1251-1253, Weinshenker,B.G.,et al, 1990
Retroviruses & Multiple Sclerosis. II. Failure of Gene Amplification Techniques to Detect Viral Sequences
Neurol 40:1254-1258, Dekaban,G.A.&Rice,G.P.A., 1990
Cortical-Basal Ganglionic Degeneration
Neurol 40:1203-1212, Riley,D.E.,et al, 1990
Striatonigral Degeneration:Clinical, MRI, & Pathologic Correlation
Neurol 40:710-711, O'Brien,C.,et al, 1990
Respiratory Dysfunction Due to L-Dopa Therapy for Parkinsonism:Diagnosis Using Serial Pulmonary Function Tests
Am J Med 89:109-114, Zupnick,H.M.,et al, 1990
Vasodilatation and Migraine
Lancet 335:822-823, , 1990
Vasoactive Peptide Release in the Extracerebral Circulation of Humans During Migraine Headache
Ann Neurol 28:183-187, Goadsby,P.J.,et al, 1990
Cognitive Change Following MPTP Exposure
Neurol 40:261-264, Stern,Y.,et al, 1990
The Dystonias
BMJ 300:139-144, Marsden,C.D.&Quinn,N.P., 1990
Amyotrophic Lateral Sclerosis:A Case-Control Study Following Detection of a Cluster in a Small Wisconsin Community
Arch Neurol 47:38-41, Sienko,D.G.,et al, 1990
Mortality Associated with Early and Late Levodopa Therapy Initiation in Parkinson's Disease
Neurol 40:265-269, Scigliano,G.,et al, 1990
Bromocriptine-Induced Hypothermia
Neurol 40:383, Pfeiffer,R.F., 1990
Dopa-Responsive Dystonia:The Spectrum of Clinical Manifestations in a Large North American Family
Neurol 40:66-69, Nygaard,T.G.,et al, 1990
Levodopa-Induced Dyskinesia:Review, Observations, and Speculations
Neurol 40:340-345, Nutt,J.G., 1990
Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990
A Large Kindred with Autosomal Dominant Parkinson's Disease
Ann Neurol 27:276-282, Golbe,L.I.,et al, 1990
The Changing Patterns of Death Rates in Parkinsonism
Neurol 40:42-49, Kurtzke,J.F.&Murphy,F.M., 1990
Stereotaxic Thalamotomy-Experiences from the Levodopa Era
JNNP 53:427-430, Wester,K.&Hauglie-Hanssen,E., 1990
Temporal Arteritis Presenting as an Extrapyramidal Disorder
ActaNeurolScand 81:361-362, Santambrogio,L.,et al, 1990
Antecollis in Parkinsonism
Lancet 1:1320-1321, Jorens,P.G.,et al, 1989
Selegiline Use to Prevent Progression of Parkinson's Disease
Arch Neurol 46:1275-1279, Elizan,T.S.,et al, 1989